These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11237677)

  • 1. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
    Harvey BG; Hackett NR; Ely S; Crystal RG
    Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
    Harvey BG; Hackett NR; El-Sawy T; Rosengart TK; Hirschowitz EA; Lieberman MD; Lesser ML; Crystal RG
    J Virol; 1999 Aug; 73(8):6729-42. PubMed ID: 10400771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of quantitative TaqMan real-time PCR to track the time-dependent distribution of gene transfer vectors in vivo.
    Hackett NR; El Sawy T; Lee LY; Silva I; O'Leary J; Rosengart TK; Crystal RG
    Mol Ther; 2000 Dec; 2(6):649-56. PubMed ID: 11124067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes.
    Ben-Gary H; McKinney RL; Rosengart T; Lesser ML; Crystal RG
    Mol Ther; 2002 Aug; 6(2):287-97. PubMed ID: 12349828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses of healthy individuals to intradermal administration of an E1-E3- adenovirus gene transfer vector.
    Harvey BG; Worgall S; Ely S; Leopold PL; Crystal RG
    Hum Gene Ther; 1999 Nov; 10(17):2823-37. PubMed ID: 10584928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.
    Mastrangeli A; Danel C; Rosenfeld MA; Stratford-Perricaudet L; Perricaudet M; Pavirani A; Lecocq JP; Crystal RG
    J Clin Invest; 1993 Jan; 91(1):225-34. PubMed ID: 8423221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway.
    Scaria A; St George JA; Gregory RJ; Noelle RJ; Wadsworth SC; Smith AE; Kaplan JM
    Gene Ther; 1997 Jun; 4(6):611-7. PubMed ID: 9231078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
    Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
    Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene.
    van Ginkel FW; McGhee JR; Liu C; Simecka JW; Yamamoto M; Frizzell RA; Sorscher EJ; Kiyono H; Pascual DW
    J Immunol; 1997 Jul; 159(2):685-93. PubMed ID: 9218583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
    Yei S; Mittereder N; Tang K; O'Sullivan C; Trapnell BC
    Gene Ther; 1994 May; 1(3):192-200. PubMed ID: 7584081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
    Kaplan JM; St George JA; Pennington SE; Keyes LD; Johnson RP; Wadsworth SC; Smith AE
    Gene Ther; 1996 Feb; 3(2):117-27. PubMed ID: 8867859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient gene transfer to airway epithelium using recombinant Sendai virus.
    Yonemitsu Y; Kitson C; Ferrari S; Farley R; Griesenbach U; Judd D; Steel R; Scheid P; Zhu J; Jeffery PK; Kato A; Hasan MK; Nagai Y; Masaki I; Fukumura M; Hasegawa M; Geddes DM; Alton EW
    Nat Biotechnol; 2000 Sep; 18(9):970-3. PubMed ID: 10973218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
    Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates.
    Scaria A; Sullivan JA; St George JA; Kaplan JM; Lukason MJ; Morris JE; Plog M; Nicolette C; Gregory RJ; Wadsworth SC
    Mol Ther; 2000 Nov; 2(5):505-14. PubMed ID: 11082324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
    Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
    Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector.
    Reix P; Bellon G; Bienvenu J; Pavirani A; Levrey-Hadden H
    Eur Cytokine Netw; 2002; 13(3):324-30. PubMed ID: 12231476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.